PHARMARON: JPMorgan Chase & Co. Acquires Shares, Long Position Rises to 15.31%
HK Disclosure
Oct 05
On September 29, 2026, JPMorgan Chase & Co. acquired 3.18 million shares of PHARMARON (H shares) off-exchange by way of taking a security interest in shares at an average of HKD 30.3314 per share, involving about HKD 96.55 million. The nature of consideration was cash. This off-exchange transaction was not matched on the SEHK open market and therefore is not a direct secondary-market dealing.
Prior to the acquisition, JPMorgan Chase & Co.'s long position in PHARMARON was 51.96 million shares, representing 14.43%; following the acquisition, the holding changed to 55.14 million shares, with the long position ratio rising to 15.31%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.